Page last updated: 2024-08-24

triazoles and nimesulide

triazoles has been researched along with nimesulide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiao, J; Liao, Q; Xiang, H1
Muller, CD; Peluso, J; Saab, L; Ubeaud-Sequier, G1
Anireddy, J; Devi, YP; Kapavarapu, R; Mangamoori, LN; Mareddy, J; Nallapati, SB; Pal, S1

Reviews

1 review(s) available for triazoles and nimesulide

ArticleYear
Recent advancement in nonsteroidal aromatase inhibitors for treatment of estrogen-dependent breast cancer.
    Current medicinal chemistry, 2010, Volume: 17, Issue:30

    Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chromones; Coumarins; Female; Flavonoids; Humans; Letrozole; Nitriles; Receptors, Estrogen; Sulfonamides; Triazoles

2010

Other Studies

2 other study(ies) available for triazoles and nimesulide

ArticleYear
Implication of hepatic transporters (MDR1 and MRP2) in inflammation-associated idiosyncratic drug-induced hepatotoxicity investigated by microvolume cytometry.
    Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2013, Volume: 83, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Sub-Family B Member 4; Biological Transport; Chemical and Drug Induced Liver Injury; Flow Cytometry; Fluoroquinolones; Gene Expression Regulation; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Ketolides; Lipopolysaccharides; Liver; Naphthyridines; Piperazines; Sulfonamides; Triazoles; Tumor Necrosis Factor-alpha; Xenobiotics

2013
Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: Alkynes; Apoptosis; Azides; Binding Sites; Catalytic Domain; Cell Line, Tumor; Copper; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloaddition Reaction; Enzyme Activation; Humans; Molecular Docking Simulation; Phosphodiesterase 4 Inhibitors; Sulfonamides; Triazoles

2013